Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1993-03-15
1997-05-20
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514120, A61K 3166
Patent
active
056312466
ABSTRACT:
The use of platelet-activating factor (PAF) to increase the levels of von Willebrand factor and/or Factor VIII in blood is disclosed. The use of PAF has particular application in the treatment of von Willebrand disease and haemophilia A.
REFERENCES:
patent: 5091363 (1992-02-01), Heimburger et al.
Camussi et al., J Immunol 131(5):2397-2403 (1983).
Tranquille et al., Eur J Pharmacol 213(2):285-292 (1992).
Tranquille et al., Thromb Haemostasis 66(4):479-483 (1991).
Tranquille et al. J Cardiovasc Pharmacol 18(1):35-42 (1991).
Tranquille et al., Thromb Haemostasis 63(3):454-8 (1990).
The Merck Manual of Diagnosis & Therapy, 16th ed., Merck & Co, Rahway, NJ 1992.
Braquet, P., and D. Hosford, (1991) "Ethnopharmacology and the Development of Natural PAF Antagonists as Therapeutic Agents", Journal of Ethnopharmacology 32:153-139.
Hanahan, D.J., (1986) "Platelet Activating Factor: A Biologically Active Phosphoglyceride", Ann. Rev. Biochem. 55:483-509.
Heller, R., et al., (1992) "Human Endothelial Cells Are Target For Platelet-Activating Factor", J. Immunology 149(11):3682-3688.
Hwang, S., (1991) "Function and Regulation of Extracellular and Intracellular Receptors of Platelet Activating Factor", Annals of the New York Academy of Sciences 629:217-226.
O'Flaherty, J.T. and R.L. Wykle, (1989) "PAF and Cell Activation", Frontiers in Pharmacology and Therapeutics: Platelet Activating Factor and Human Disease, Blackwell Scientific Publications, chapter 5, pp. 117-137.
Prescott, S.M. et al., (1984) "Human Endothelial Cells in Culture Produce Platelet-Activating Factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) When Stimulated With Thrombin", Proc. Natl. Acad. Sci. USA 81:3534-3538.
Prescott, S.M., et al., (1990) "The Role of Platelet-Activating Factor in Endothelial Cells", Thrombosis and Haemostasis 64(1):99-103.
Rola-Pleszczynski, M., (1990) "Priming of Human Monocytes with PAF Augments Their Production of Tumor Necrosis Factor", Journal of Lipid Mediators 2:s77-s82.
Snyder, F., (1987) "Composition of Alkyl Ether-Linked Phospholipids in Mammalian Tissues", Platelet-Activating Factor and Related Lipid Mediators, Plenum Press, chapter 3, pp. 55-85.
Snyder, F., (1990) "Platelet-Activating Factor and Related Acetylated Lipids as Potent Biologically Active Celullar Mediators", Am. J. Physiol. 259(Cell Physiol. 28):C697-C708.
Vargaftig, B.B., et al., (1981) "Background and Present Status of Research on Platelet-Activating Factor (PAF-Acether)", Annals New York Academy of Sciences, 370:119-137.
Whatley, R.E., et al., (1987) "Production of Platelet-Activating Factor by Endothelial Cells", Seminars in Thrombosis and Hemostasis 13(4):445-453.
Zimmerman, G.A., et al., (1990) "Endothelial Cells for Studies of Platelet-Activating Factor and Arachidonate Metabolites", Methods In Enzymology 187:520-535.
Hashemi Sofia
Palmer Douglas
The Canadian Red Cross Society
Wityshyn Michael G.
Witz Jean C.
LandOfFree
Use of PAF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of PAF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of PAF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1724020